Pharmaceutical Analytical Testing Outsourcing Market Future Prospects
The global pharmaceutical analytical testing outsourcing market size in 2024 is USD 9.4 billion, and it is expected to advance at a CAGR of 8.7% during 2025–2032, to reach USD 18.1 billion by 2032. This is ascribed to the innovations in the pharmaceutical industry; the increased emphasis on safety, regulation, and quality; the rise in the number of end users; and the cost advantages of outsourcing.
Increased R&D expenditure is one of the essential sustainability methods employed by participants in the industry. Not every business has the infrastructure necessary for every kind of analytical testing. Thus, outsourcing these tasks is a suitable alternative, saving both money and time.
Pharmaceuticals are in greater demand now than before the COVID-19 pandemic. In the time of crisis, outsourcing providers of pharmaceutical analytical testing were crucial in addressing the testing demands of pharmaceutical corporations, contract research organizations (CROs), biotechnological companies, and other end users, worldwide.